1. Home
  2. CDZI vs ADCT Comparison

CDZI vs ADCT Comparison

Compare CDZI & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CADIZ Inc.

CDZI

CADIZ Inc.

HOLD

Current Price

$4.93

Market Cap

410.6M

Sector

Utilities

ML Signal

HOLD

Logo ADC Therapeutics SA

ADCT

ADC Therapeutics SA

HOLD

Current Price

$3.78

Market Cap

484.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDZI
ADCT
Founded
1983
2011
Country
United States
Switzerland
Employees
25
N/A
Industry
Water Supply
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
410.6M
484.4M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
CDZI
ADCT
Price
$4.93
$3.78
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.75
AVG Volume (30 Days)
473.0K
793.8K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.86
EPS
N/A
N/A
Revenue
N/A
$81,357,000.00
Revenue This Year
$23.80
N/A
Revenue Next Year
$125.51
$68.29
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.85
52 Week Low
$2.13
$1.05
52 Week High
$6.96
$4.98

Technical Indicators

Market Signals
Indicator
CDZI
ADCT
Relative Strength Index (RSI) 45.57 44.17
Support Level $4.46 $3.65
Resistance Level $5.81 $3.87
Average True Range (ATR) 0.25 0.21
MACD 0.02 -0.04
Stochastic Oscillator 54.74 33.79

Price Performance

Historical Comparison
CDZI
ADCT

About CDZI CADIZ Inc.

Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, which derives key revenue, and comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, which provides water filtration solutions for impaired or contaminated groundwater sources.

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Share on Social Networks: